Sickle cell disease can mean a lifetime of pain, hospital stays, and uncertainty—but a breakthrough gene therapy is offering new hope. In this Gateway to Wellness segment, sponsored by Regenerative Neuropathy, we meet 20-year-old Martin Mwita Jr., who came to St. Louis searching for a way out of sickle cell anemia. Through an FDA-approved treatment called Lyfgenia, Martin’s own stem cells were modified and returned to his body—dramatically reducing his sickled cells and helping him reclaim his life. Board-certified physician Dr. Rhea Rogers explains how the therapy works, who might qualify, and why it could be life-changing for some patients living with this devastating disease.
Look of the Week by Mango
Counter clockwise from left to right:Metallic Rigid Choker,Rigid Bracelet,Zipped Biker Jacket,Shift Dress,Leather Lapel Envelope











